Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Design and development of the theranostic pair 177Lu‐OPS201/68Ga‐OPS202 for targeting somatostatin receptor expressing tumors | Journal of Labelled Compounds and Radiopharmaceuticals |
| 19 | 2019 |
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy | European Journal of Nuclear Medicine and Molecular Imaging |
| 16 | 2020 |
What Is Theranostics? | Journal of Nuclear Medicine |
| 11 | 2023 |
PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference | Journal of Nuclear Medicine |
| 178 | 2011 |